BioSpace News Archive

Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced that Robert Cobuzzi, Jr., Ph.D., the Company’s President and Chief Executive Officer, will be presenting at the H.C. Wainwright Global Investment Conference.

DUBAI, United Arab Emirates, With the growing income of people across the globe, they are willing to pay more for healthcare, the revenue being generated by hospitals is also increasing rapidly.

The professional intelligence studies predict that the global dental consumables market will expand at a stable annual compound growth rate of 5.2 % over the forecast period of 2017 to 2023.

The rise in living standards of people, change in quality life, and rising demand for quality products stands as a key factor boosting the growth of the global cleanroom technology market.

Albany NY, United States: The expanding elder population, rise in food safety concerns, improving healthcare infrastructure, and higher healthcare expenditure are the important factors likely to drive growth of the global atomic emission spectrometry market.

The corporate intelligence studies predict that the global pharmacy automation market will expand at an incredible growth rate of 7.8 % over the forecast period of 2022 to 2027.

Albany NY, United States: The global measles testing market is expected to witness moderate growth during the forecast period between 2021 and 2031.

The latest research report indicates the global sterility testing market displayed an outstanding compound annual growth rate of 12.3 % over the forecast period of 2016 to 2021.

DUBAI, United Arab Emirates, Increasing volume of spinal cord surgeries to correct various anomalies is acting as the principal growth driver for the market.

OKYO Pharma Limited, a life sciences company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, is pleased to announce the pricing of the underwritten initial public offering of its American Depositary Shares on the Nasdaq Capital Market.